WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'7701 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 9'4331 Child (under 5 years) mortality rate: 282

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 2'881  2'839  2'796  2'754  2'713  2'397  2'184  1'690 
Births 64  64  64  63  62  46  69  66 
Surviving infants 63  63  62  62  61  44  64  59 
Pop. less than 5 years 310  309  306  297  280  234  332  275 
Pop. less than 15 years 790  774  760  746  731  834  884  738 
Female 15-49 years 832  830  826  822  817  656  527  370 

Number of reported case

(Click for retrospective incidence data for Mongolia)
Diphtheria
Japanese encephalitis
Measles 925  296  5'338 
Mumps 425  5'268  9'060  1'016  524  874 
Pertussis 22 
Polio*
Rubella 240  13  11  1'550 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mongolia)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   85  99  99  99  99  99  97 
DTP1 2009  96  MICS   85  99  98  99*  99  98  95 
DTP3 2009  92  MICS   85  99  98  99*  99  96  95 
HepB_BD          97  97  97  96  95  96 
HepB3          99  98  99*  99  96  93 
Hib3          99  98  99*  99  96 
JapEnc         
MCV          98  97  99  98  97  92 
MCV2          98  97  98  98  95  75 
PCV1         
PCV3         
Pol3 2009  94  MICS   85  99  98  99*  99  96  94 
Rota1         
Rota_last         
Rubella1          98  97  99  98  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mongolia)
BCG 99  99  99  99  97  81  51 
DTP1 98  99  99  98  95  94  91 
DTP3 98  99  99  96  94  84  76 
HepB3 98  99  99  96  93 
HepB_BD 97  97  96  95  96 
Hib3 98  99  99  96 
MCV 97  99  98  97  92  92  17 
MCV2 97  98  98  95  75 
PCV3
Pol3 98  99  99  96  94  87  86 
Rota_last

Number of districts in the country 339  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7, 15 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepA 14 months; 2 years; Yes
HepB birth; Yes
IPV Yes From October 2015
Influenza_Adult > 15 years; and adults with chronic illness, health care workers, Haj and other travellers
Influenza_Pediatric 3-14 years; and children with chronic illness
MMR 9 months: 2 years; Yes
OPV birth; 2, 3, 4 months; Yes
VitaminA 0-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2008-2012  2008-2012  2007-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 339  339  338  48  71  127  356 

System performance

Total Nº districts in country number 339  339  338  338  340  338  356 
Nº districts with DTP3 coverage >=80% number 339  338  338  338  339  337  356 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 339  327  325  323  319  307  329 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  96  96  96  94  91  92 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 74  95  74  69  24  46  22 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.